Heron Therapeutics (HRTX) Shareholder's Equity (2010 - 2026)

Heron Therapeutics (HRTX) Shareholder's Equity (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 7.14 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 795.79 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 595,226.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 14.38 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.37 Bn 94.37 Bn - 502.95 Mn
10 Heron Therapeutics 85.57 Mn 55.60 Mn 24.07 Mn 9.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.14 Mn
Dec 31, 2025 14.33 Mn
Sep 30, 2025 14.89 Mn
Jun 30, 2025 -27.26 Mn
Mar 31, 2025 -28.45 Mn
Dec 31, 2024 -33.65 Mn
Sep 30, 2024 -40.01 Mn
Jun 30, 2024 -37.94 Mn
Mar 31, 2024 -33.77 Mn
Dec 31, 2023 -33.97 Mn
Sep 30, 2023 -27.79 Mn
Jun 30, 2023 -39.28 Mn
Mar 31, 2023 -11.43 Mn
Dec 31, 2022 13.57 Mn
Sep 30, 2022 22.45 Mn
Jun 30, 2022 -21.74 Mn
Mar 31, 2022 23.96 Mn
Dec 31, 2021 77.57 Mn
Sep 30, 2021 118.84 Mn
Jun 30, 2021 160.11 Mn